Long-term survivors with artificial liver support in fulminant heptic failure

Therapeutic Apheresis

Volumn 6, Issue 3, 2002, Pages 208-212

  Nitta, Masakazu ^a   Hirasawa, Hiroyuki ^a   Oda, Shigeto ^a   Shiga, Hidetoshi ^a   Nakanishi, Kazuya ^a   Matsuda, Kenichi ^a   Nakamura, Masataka ^a   Yokohari, Kennji ^a   Hirano, Takeshi ^a   Hirayama, Yoh ^a   Moriguchi, Takeshi ^a   Watanabe, Eizou ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Artificial liver support; Fulminant hepatic failure; High flow dialysate continuous hemodiafiltration; Intracranial pressure; Long term survivors; Slow plasma exchange

Indexed keywords

ADULT; ARTICLE; ARTIFICIAL LIVER; CLINICAL ARTICLE; EXPERIENCE; FEMALE; HEMODIALYSIS; HUMAN; INFECTION RISK; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; LIVER TRANSPLANTATION; MALE; PLASMAPHERESIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SURVIVAL TIME; TREATMENT INDICATION;

ADULT; FEMALE; HEMODIAFILTRATION; HEPATIC ENCEPHALOPATHY; HUMANS; INTENSIVE CARE UNITS; LIVER FAILURE; LIVER REGENERATION; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; MALE; MIDDLE AGED; PLASMA EXCHANGE; SURVIVORS;

EID: 0036317718     PISSN: 10916660     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-0968.2002.00434.x     Document Type: Article

References (21)

1. Liver transplantation for fulminant hepatic failure
2. Indications for orthotopic liver transplantation in fulminant liver failure
3. Fulminant hepatic failure: Summary of a workshop
4. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure
5. Efficacy and limitation of apheresis therapy in critical care
6. Circulating proinflammatory cytokines (IL-1β, TNF-α, and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis
7. Plasma inhibitory activity against tumour necrosis factor in fulminant hepatic failure
8. Bacterial and fungal infection in acute liver failure
9. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure
10. High level of serum interleukin-10 and tumor necrosis factor-α are associated with fatality in fulminant hepatitis
11. Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis?
12. Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS
13. Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients
14. Hemofiltration increases IL-6 clearance in early systemic inflammatory response syndrome but does not alter IL-6 and TNFα plasma concentrations
15. Can continuous hemodiafiltration remove cytokine? Possibility of non-renal indication of continuous hemodiafiltration
16. Current topics on cytokine removal technologies
17. Usefulness of plasma exchange plus continuous hemodiafiltration to reduce adverse effects associated with plasma exchange in patients with acute liver failure
18. Intracranial pressure monitoring and liver transplantation for fulminant hepatic failure
19. Living-related liver transplantation and neurological outcome in children with fulminant hepatic failure
20. Prospective study of bacterial infection in acute liver failure: An analysis of fifty patients
21. Selective bowel decontamination of recipients for prevention against liver injury following orthotopic liver transplantation: Evaluation with rat models